You are here

Clinical Trials: Vascular Disease



Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, June 2, 2016 - 12:00
Conditions:   End Stage Renal Disease (ESRD);   Vascular Access Complication
Intervention:   Biological: Adipose Derived Mesenchymal Stem Cells (AMSC)
Sponsor:   Mayo Clinic
Not yet recruiting - verified June 2016
Posted: Monday, May 30, 2016 - 12:00
Conditions:   Peripheral Vascular Disease;   Ischemia;   Diabetic Foot
Interventions:   Biological: mesenchymal stem cells;   Biological: saline
Sponsors:   Jie Shen;   Nanfang Hospital of Southern Medical University;   Academy Military Medical Science, China;   The Fifth Affiliated Hospital of Southern Medical University;   Southern Medical University, China
Recruiting - verified June 2016
Posted: Tuesday, May 17, 2016 - 12:00
Condition:   Stroke
Interventions:   Behavioral: Mirror Box Therapy;   Behavioral: Sham Mirror Box Therapy
Sponsors:   Columbia University;   Helen Hayes Hospital
Not yet recruiting - verified May 2016
Posted: Friday, May 13, 2016 - 12:00
Condition:   Diabetic Foot Ulcers
Intervention:   Device: Passive knee extensor machine
Sponsors:   Herlev Hospital;   University of Copenhagen
Recruiting - verified May 2016
Posted: Monday, May 2, 2016 - 12:00
Conditions:   Peripheral Artery Disease;   Vascular Disease;   Critical Limb Ischemia
Intervention:   Device: Injection of cBMA aspirate into the index leg
Sponsors:   Michael Murphy;   Biomet, Inc.
Not yet recruiting - verified August 2016
Posted: Monday, April 25, 2016 - 12:00
Condition:   Peripheral Arterial Disease
Interventions:   Procedure: Lipoaspiration;   Other: Intravenous injection of Adipose Derived Stem Cells;   Other: Intra-adventitia (proximal to the lesion) injection of Adipose Derived Stem Cells;   Other: Intra-muscular injection of Adipose Derived Stem Cells;   Other: Low Frequency Ultrasound (LoFU) Delivery
Sponsors:   Arkansas Heart Hospital;   National Institutes of Health (NIH);   SonaCare Medical
Recruiting - verified April 2016
Posted: Thursday, April 7, 2016 - 12:00
Condition:   Skin Ulcer Venous Stasis Chronic
Intervention:   Biological: APZ2 application
Sponsors:   Rheacell GmbH & Co. KG;   FGK Clinical Research GmbH;   Granzer Regulatory Consulting & Services
Recruiting - verified May 2016
Posted: Wednesday, March 16, 2016 - 12:00
Conditions:   Stable Angina;   Unstable Angina;   STEMI;   NSTEMI;   Coronary Disease
Interventions:   Device: COMBO-Stent;   Drug: Clopidogrel, Vitamin K Antagonist, Rivaroxaban, Dabigatran;   Device: Any drug eluting stent oder bare metal sent;   Drug: ASA, Clopidogrel, Vitamin K Antagonist, Rivaroxaban, Dabigatran
Sponsors:   IHF GmbH - Institut für Herzinfarktforschung;   OrbusNeich
Not yet recruiting - verified March 2016
Posted: Tuesday, March 1, 2016 - 12:00
Conditions:   AAA;   Abdominal Aortic Aneurysm;   Vascular Disease;   Peripheral Artery Disease
Interventions:   Biological: Intravenous infusion of Plasmalyte A (placebo);   Biological: Intravenous infusion of 1 million allogeneic MSCs/kg;   Biological: Intravenous infusion of 3 million allogeneic MSCs/kg
Sponsor:   Michael Murphy
Not yet recruiting - verified July 2016
Posted: Tuesday, February 2, 2016 - 12:00
Conditions:   Ischemia;   Peripheral Arterial Disease;   Peripheral Vascular Disease;   Vascular Disease;   Arterial Occlusive Disease;   Arteriosclerosis;   Atherosclerosis;   Cardiovascular Disease;   Pathologic Processes;   Orthopedic Procedures;   Amputation
Intervention:   Biological: Allogeneic bone marrow derived mesenchymal stem cells
Sponsor:   Indiana University
Recruiting - verified February 2016